ANACOR PHARMACEUTICALS INC COM
ANAC
ANAC was delisted on the 23rd of June, 2016.
147 hedge funds and large institutions have $1.29B invested in ANACOR PHARMACEUTICALS INC COM in 2014 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 40 increasing their positions, 45 reducing their positions, and 12 closing their positions.
267% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 12
38% more capital invested
Capital invested by funds: $940M → $1.29B (+$354M)
27% more funds holding
Funds holding: 116 → 147 (+31)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
11% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 45
33% less call options, than puts
Call options by funds: $3.59M | Put options by funds: $5.32M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.2M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$13.5M |
| 3 |
CCM
Consonance Capital Management
New York
|
+$12.9M |
| 4 |
Millennium Management
New York
|
+$12.9M |
| 5 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$12.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$39.7M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$17.1M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$9.9M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$9.65M |
| 5 |
BC
Broadfin Capital
New York
|
-$8.3M |
ANAC Hedge Fund Activity: Q4 2014 in Review
147 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q4 2014, worth a combined $1.29B — up 38% from $940M a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new ANAC positions and 12 closed out — a net gain of 32 holders — while 40 added to existing stakes and 45 trimmed.
The largest buyer was Vanguard Group, adding an estimated $18.2M. The largest seller was Wellington Management Group, cutting an estimated $39.7M.
- 147 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q4 2014, up from 116 in Q3 2014.
- Funds reported $1.29B of ANACOR PHARMACEUTICALS INC COM stock for Q4 2014, up 38% quarter-over-quarter.
- 44 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q4 2014 and 12 closed out, a net change of +32 holders.
- The largest ANACOR PHARMACEUTICALS INC COM buyer in Q4 2014 was Vanguard Group, an estimated $18.2M added.
- The largest ANACOR PHARMACEUTICALS INC COM seller in Q4 2014 was Wellington Management Group, an estimated $39.7M sold.
Based on aggregated 13F filings for Q4 2014.